Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2016

01.02.2016 | Retinal Disorders

Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy

verfasst von: Patrik Schatz, Dror Sharon, Sermed Al-Hamdani, Sten Andréasson, Michael Larsen

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Our aim was to analyze retinal structure in young patients with Best disease with reference to future gene therapy.

Methods

This was a retrospective observational spectral domain optical coherence tomography study of four patients aged 10 years or less with Best disease.

Results

Findings ranged from subtle thickening at the level of the retinal pigment epithelium-photoreceptor interdigitation line, to subretinal fluid and precipitate-like changes at the level of the photoreceptor outer segments, and further to choroidal neovascularization. The photoreceptor inner segment ellipsoid layer could be visualized seemingly undisturbed above the vitelliform lesions, except in the case of choroidal neovascularization.

Conclusions

Clinical variability is evident even among young patients aged 10 years or less with Best disease. The earliest structural alterations seem to occur at the level of the retinal pigment epithelium-photoreceptor interdigitation line. The photoreceptor inner segment seems to be unaffected unless choroidal neovascularization develops, which seems promising regarding future gene therapy.
Literatur
2.
Zurück zum Zitat Yardley J, Leroy BP, Hart-Holden N et al (2004) Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 45:3683–3689PubMedCrossRef Yardley J, Leroy BP, Hart-Holden N et al (2004) Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 45:3683–3689PubMedCrossRef
3.
Zurück zum Zitat Bitner H, Mizrahi-Meissonnier L, Griefner G, Erdinest I, Sharon D, Banin E (2011) A homozygous frameshift mutation in BEST1 causes the classical form of Best disease in an autosomal recessive mode. Invest Ophthalmol Vis Sci 52:5332–5338PubMedCrossRef Bitner H, Mizrahi-Meissonnier L, Griefner G, Erdinest I, Sharon D, Banin E (2011) A homozygous frameshift mutation in BEST1 causes the classical form of Best disease in an autosomal recessive mode. Invest Ophthalmol Vis Sci 52:5332–5338PubMedCrossRef
4.
5.
Zurück zum Zitat Burgess R, MacLaren RE, Davidson AE et al (2009) ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet 46:620–625PubMedCrossRef Burgess R, MacLaren RE, Davidson AE et al (2009) ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet 46:620–625PubMedCrossRef
6.
Zurück zum Zitat Bitner H, Schatz P, Mizrahi-Meissonnier L, Sharon D, Rosenberg T (2012) Frequency, genotype, and clinical spectrum of best vitelliform macular dystrophy: data from a national center in Denmark. Am J Ophthalmol 154:403–412PubMedCrossRef Bitner H, Schatz P, Mizrahi-Meissonnier L, Sharon D, Rosenberg T (2012) Frequency, genotype, and clinical spectrum of best vitelliform macular dystrophy: data from a national center in Denmark. Am J Ophthalmol 154:403–412PubMedCrossRef
7.
Zurück zum Zitat Petrukhin K, Koisti MJ, Bakall B et al (1998) Identification of the gene responsible for Best macular dystrophy. Nat Genet 19:241–247PubMedCrossRef Petrukhin K, Koisti MJ, Bakall B et al (1998) Identification of the gene responsible for Best macular dystrophy. Nat Genet 19:241–247PubMedCrossRef
8.
Zurück zum Zitat Gomez NM, Tamm ER, Straubeta O (2013) Role of bestrophin-1 in store-operated calcium entry in retinal pigment epithelium. Pflugers Arch 465:481–495PubMedCrossRef Gomez NM, Tamm ER, Straubeta O (2013) Role of bestrophin-1 in store-operated calcium entry in retinal pigment epithelium. Pflugers Arch 465:481–495PubMedCrossRef
9.
Zurück zum Zitat Guziewicz KE, Slavik J, Lindauer SJ, Aguirre GD, Zangerl B (2011) Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies. Invest Ophthalmol Vis Sci 52:4497–4505PubMedPubMedCentralCrossRef Guziewicz KE, Slavik J, Lindauer SJ, Aguirre GD, Zangerl B (2011) Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies. Invest Ophthalmol Vis Sci 52:4497–4505PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Schatz P, Bitner H, Sander B et al (2010) Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1. Invest Ophthalmol Vis Sci 51:4754–4765PubMedCrossRef Schatz P, Bitner H, Sander B et al (2010) Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1. Invest Ophthalmol Vis Sci 51:4754–4765PubMedCrossRef
11.
Zurück zum Zitat Piñeiro-Gallego T, Álvarez M, Pereiro I et al (2011) Clinical evaluation of two consanguineous families with homozygous mutations in BEST1. Mol Vis 17:1607–1617PubMedPubMedCentral Piñeiro-Gallego T, Álvarez M, Pereiro I et al (2011) Clinical evaluation of two consanguineous families with homozygous mutations in BEST1. Mol Vis 17:1607–1617PubMedPubMedCentral
12.
Zurück zum Zitat Andersen MK, Christoffersen NL, Sander B et al (2010) Oligocone trichromacy: clinical and molecular genetic investigations. Invest Ophthalmol Vis Sci 51:89–95PubMedCrossRef Andersen MK, Christoffersen NL, Sander B et al (2010) Oligocone trichromacy: clinical and molecular genetic investigations. Invest Ophthalmol Vis Sci 51:89–95PubMedCrossRef
13.
Zurück zum Zitat Wittstrom E, Ekvall S, Schatz P, Bondeson ML, Ponjavic V, Andreasson S (2011) Morphological and functional changes in multifocal vitelliform retinopathy and biallelic mutations in BEST1. Ophthalmic Genet 32:83–96PubMedCrossRef Wittstrom E, Ekvall S, Schatz P, Bondeson ML, Ponjavic V, Andreasson S (2011) Morphological and functional changes in multifocal vitelliform retinopathy and biallelic mutations in BEST1. Ophthalmic Genet 32:83–96PubMedCrossRef
14.
Zurück zum Zitat Wang M, Sander B, la Cour M, Larsen M (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83:691–696PubMedCrossRef Wang M, Sander B, la Cour M, Larsen M (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83:691–696PubMedCrossRef
15.
Zurück zum Zitat Singh R, Shen W, Kuai D et al (2013) iPS cell of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 22:593–607PubMedPubMedCentralCrossRef Singh R, Shen W, Kuai D et al (2013) iPS cell of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 22:593–607PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Chung MM, Oh KT, Streb LM, Kimura AE, Stone EM (2001) Visual outcome following subretinal hemorrhage in Best disease. Retina 21:575–580PubMedCrossRef Chung MM, Oh KT, Streb LM, Kimura AE, Stone EM (2001) Visual outcome following subretinal hemorrhage in Best disease. Retina 21:575–580PubMedCrossRef
17.
Zurück zum Zitat Frennesson CI, Wadelius C, Nilsson SE (2014) Best vitelliform macular dystrophy in a Swedish family: genetic analysis and a seven-year follow-up of photodynamic treatment of a young boy with choroidal neovascularization. Acta Ophthalmol 92(3):238–242PubMedCrossRef Frennesson CI, Wadelius C, Nilsson SE (2014) Best vitelliform macular dystrophy in a Swedish family: genetic analysis and a seven-year follow-up of photodynamic treatment of a young boy with choroidal neovascularization. Acta Ophthalmol 92(3):238–242PubMedCrossRef
18.
Zurück zum Zitat Iannaccone A, Kerr NC, Kinnick TR, Calzada JI, Stone EM (2011) Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications. Arch Ophthalmol 129:211–217PubMedCrossRef Iannaccone A, Kerr NC, Kinnick TR, Calzada JI, Stone EM (2011) Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications. Arch Ophthalmol 129:211–217PubMedCrossRef
19.
Zurück zum Zitat Querques G, Zerbib J, Santacroce R et al (2011) The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. Invest Ophthalmol Vis Sci 52:4678–4684PubMedCrossRef Querques G, Zerbib J, Santacroce R et al (2011) The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. Invest Ophthalmol Vis Sci 52:4678–4684PubMedCrossRef
20.
Zurück zum Zitat Querques G, Zerbib J, Georges A et al (2014) Multimodal analysis of the progression of Best vitelliform macular dystrophy. Mol Vis 27:575–592 Querques G, Zerbib J, Georges A et al (2014) Multimodal analysis of the progression of Best vitelliform macular dystrophy. Mol Vis 27:575–592
21.
Zurück zum Zitat Ferrara DC, Costa RA, Tsang S, Calucci D, Jorge R, Freund KB (2010) Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol 248:1377–1386PubMedPubMedCentralCrossRef Ferrara DC, Costa RA, Tsang S, Calucci D, Jorge R, Freund KB (2010) Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol 248:1377–1386PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Meunier I, Manes G, Bocquet B et al (2014) Frequency and clinical pattern of vitelliform macular dystrophy caused by mutations of interphotoreceptor matrix IMPG1 and IMPG2 genes. Ophthalmology 121:2406–2414PubMedCrossRef Meunier I, Manes G, Bocquet B et al (2014) Frequency and clinical pattern of vitelliform macular dystrophy caused by mutations of interphotoreceptor matrix IMPG1 and IMPG2 genes. Ophthalmology 121:2406–2414PubMedCrossRef
Metadaten
Titel
Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy
verfasst von
Patrik Schatz
Dror Sharon
Sermed Al-Hamdani
Sten Andréasson
Michael Larsen
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2016
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-3025-z

Weitere Artikel der Ausgabe 2/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.